Medical Technology

Current search: deals

@xconomy.com 1 month ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 1 month ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 1 month ago

CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019

@xconomy.com 2 months ago

With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14

@xconomy.com 3 months ago

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

@xconomy.com 4 months ago

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

@xconomy.com 4 months ago

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B

@xconomy.com 5 months ago

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

@xconomy.com 5 months ago

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

@xconomy.com 5 months ago

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

@xconomy.com 6 months ago

UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma

@xconomy.com 6 months ago

Five Years After Y Combinator First Admits Biotechs, They’re Dug In

@xconomy.com 6 months ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 6 months ago

SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M

@xconomy.com 7 months ago

Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds

@engadget.com 8 months ago

Wirecutter's best deals: Save $300 on a Google Pixel 3

@xconomy.com 8 months ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 8 months ago

Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company

@xconomy.com 9 months ago

Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

@xconomy.com 9 months ago

WI Watchlist: Microsoft, Exact Sciences, Shine & MKE Tech Hub

@xconomy.com 9 months ago

Providence St. Joseph to Buy Wisconsin Health IT Consultant Bluetree

@xconomy.com 9 months ago

PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome

@xconomy.com 9 months ago

Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits

@xconomy.com 9 months ago

Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes

@xconomy.com 9 months ago

Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business

@xconomy.com 10 months ago

Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D

@xconomy.com 10 months ago

WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More

@xconomy.com 10 months ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More